Mira Pharmaceuticals Inc (MIRA)
1.2250 -0.0050 (-0.41%) 11:56 ET [NASDAQ]
1.2200 x 200 1.2300 x 7,200
Realtime by (Cboe BZX)
1.2200 x 200 1.2300 x 7,200
Realtime 1.1800 -0.0500 (-4.07%) 08:43 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | |
Assets | ||
Current Assets | ||
Cash & Cash Equivalents | 4,603 | 351 |
Receivables | 12 | N/A |
Other current assets | 0 | 143 |
TOTAL | $4,858 | $494 |
Non-Current Assets | ||
Other Non-Current Assets | 74 | 364 |
TOTAL | $74 | $364 |
Total Assets | $4,932 | $858 |
Liabilities | ||
Current Liabilities | ||
Short Term Debt | N/A | 133 |
Accounts payable and accrued liabilities | 539 | 928 |
Accrued Expenses | 15 | 35 |
TOTAL | $558 | $1,370 |
Non-Current Liabilities | ||
aiOther Non-Current Liabilities | 0 | 84 |
TOTAL | $N/A | $84 |
Total Liabilities | $558 | $1,454 |
Shareholders' Equity | ||
Shares Outstanding, K | 14,781 | N/A |
Common Shares | 2 | 7 |
Retained earnings | -21,285 | -9,303 |
TOTAL | $4,374 | $-596 |
Total Liabilities And Equity | $4,932 | $858 |